Participated · Series A · Jun 2026

Limitless Labs builds a Physical AI Foundation Model trained on metal cutting physics, CAD geometry, and machine constraints to power a CAM Agent that automates CNC programming inside CAD/CAM systems like Mastercam, Siemens NX, and PTC Creo. The CAM Agent identifies features, recommends tools and operation sequences, generates toolpaths, and produces shop-floor-ready programs while keeping engineers in control. Customers claim the platform can reduce CNC programming time by up to 50%, and the company has production deployments with Blue Origin, Cadillac F1, Sandvik, and Iscar. The platform supports deployment across cloud, private VPC, and AWS GovCloud and is ITAR-compliant for regulated industries. Financially, the company has raised $27.3 million to date, including a $20 million Series A announced in June 2026. Planned uses of recent funding include U.S. commercial expansion, advancing closed-loop CNC automation, growing the CAM Agent, expanding the Tel Aviv research lab, and roughly doubling headcount over the next year.

Led · Seed · Apr 2025

Hopper is a New York- and Tel Aviv-based cybersecurity startup providing a platform to manage modern software security risk. It positions itself as a modern alternative to Software Composition Analysis (SCA), offering function-level reachability, automated asset discovery, hidden vulnerability detection, and support for complex web frameworks. The company simulates how applications are built and executed to provide deep visibility without agents or CI/CD integration. Hopper supports full SBOM and VEX export, agentless deployment via read-only Git access, and delivers contextual remediation evidence linked directly to source. Its platform detects internal and shadow dependencies and is already used by Fortune 500s and tech companies to replace legacy SCA tools. Hopper emerged from stealth and raised $7.6M in seed funding.

Participated · Series A · Dec 2024

NeuroKaire develops a clinical test that uses a simple blood draw and patient‑derived neurons to provide a neuronal readout of antidepressant effects, combined with clinical data and a pharmacogenetic screen covering 132 drugs. The test is designed to help clinicians identify the optimal antidepressant for individual patients, reduce trial‑and‑error prescribing, and enable faster, lower‑dose, and safer treatment. NeuroKaire also positions its technology for pharmaceutical and biotechnology partners to bring precision medicine into drug development across psychiatry and neurology. The company said it will use new funding to scale operations, expand its team, deepen research and development, and expand pharmaceutical partnerships focused on multiple psychiatric and neurological diseases. The announcement highlights ongoing efforts to expand pharmaceutical collaborations and to deploy the test in clinical and drug‑development settings. The company is based in Kearny, N.J. Genetika+ builds personalized medicine solutions for psychiatric and neurological diseases using its Brain-in-a-Dish technology. The company’s first indication, NeuroKaire, rapidly tests more than 70 approved antidepressants and combinations against an individual patient’s neurological biomarkers. Genetika+ combines these functional readouts with patients’ genetic and medical history to predict optimal drug or combination therapies, aiming to reduce trial-and-error prescribing, side effects, and time to effective treatment. The platform is positioned to enable faster treatment, lower dosing, and fewer adverse outcomes versus current practice. Several clinical studies are underway and additional trials are planned to further validate the tool. Genetika+ was founded in 2018 by Talia Cohen-Solal and Daphna Laifenfeld and is based in Tel Aviv, Israel.

Participated · Seed · Oct 2024

Eon is a cloud infrastructure company that converts static backups from AWS, Microsoft Azure, and Google Cloud into a single, browsable, searchable, and queryable data lake. Built by the team that created AWS Disaster Recovery and Migration services, the platform automates data ingestion, unifies multi-cloud stores, and provides self-service access through one pane of glass. Customers report cutting data-preparation workflows by over 90 % and reducing backup costs by 30 %–50 % while lowering compliance risk. Eon’s technology lets enterprises use historically untapped backup data for AI training, analytics, governance, and rapid recovery. With exploding demand, the company plans to accelerate R&D, expand global hiring, scale U.S. go-to-market efforts, and deepen integrations with AWS, Azure, and Google Cloud. Less than two years after launch, Eon has raised $500 million in total funding and is now valued at $4 billion.

Participated · Seed · Jun 2023

Nokod Security builds a platform that enables organizations to secure low-code/no-code custom applications and robotic process automation by scanning for security and compliance issues and applying customized auto-remediation policies. The platform gives security teams a comprehensive view of application inventory, identifies vulnerabilities, and accelerates digital transformation through automated remediation. Founded in 2023 by CEO Yair Finzi and CTO Amichai Shulman, the company is based in Tel Aviv, Israel. Nokod raised $8M in Seed funding and plans to use the proceeds to establish a presence in the United States and expand its R&D teams. It also intends to support novel research into security vulnerabilities specific to the low-code/no-code domain. The company is in discussions with Fortune 500 companies across several verticals.